Placeholder

Piclib

API-Palbociclib

Packaging-1 Bottle of 21 Capsules

Strength-125 mg

Get an Enquiry
Category: Tags: ,

Description

Piclib, containing the active substance palbociclib, is a kinase inhibitor used for the treatment of adult patients with HR-positive, HER-2 negative advanced, or metastatic breast cancer. The medicine Piclib is used in combination with aromatase inhibitors as initial endocrine-based therapy in postmenopausal women or in men. Or it can be also used in combination with fulvestrant in patients with disease progression following endocrine therapy.

Dosage and Side Effects

The recommended starting dose of PICLIB is a 125 mg capsule once daily taken with food for 21 days followed by 7 days of treatment. PICLIB capsules are taken orally with food in combination with an aromatase inhibitor or fulvestrant. When given with PICLIB, the proposed dose of fulvestrant is 500 mg administered on Days 1, 15, and 29, and once monthly thereafter. Patients must take their dose of Piclib at approximately the same time each day. In case of a missed dose, an additional dose should not be taken. The very next prescribed dose should be taken at around the usual time. Piclib capsules should be swallowed whole (do not crush, chew, or open them prior to swallowing).

The most commonly reported PICLIB-palbociclib side effects include: infections, vomiting, neutropenia, leukopenia, fatigue, nausea, stomatitis, anemia, alopecia, diarrhea, thrombocytopenia, rash, decreased appetite, pyrexia, and asthenia.

Warning and Precautions

  • Neutropenia may occur in patients taking treatment with Piclib. Monitor complete blood counts prior to starting Piclib treatment. And the beginning of each cycle, as well as on Day 15 of the first 2 cycles.
  • Febrile neutropenia may occur in patients exposed to Piclib (palbociclib 125 mg) capsules. Health specialists should inform their patients to quickly report any episodes of fever.
  • Findings suggest that PICLIB can cause fetal harm when administered to a pregnant woman. The respective females of reproductive age/potential must use effective contraception throughout the treatment and for at least 3 weeks following the final dose.
  • There are no deets regarding the presence of palbociclib in human milk or its effect on the breastfed child. Due to the potential of severe side effects in a breastfed child, lactating women should not breastfeed during treatment with Piclib and for 3 weeks after the final palbociclib dosage.
  • Grapefruit may interact with PICLIB. Patients receiving treatment with this medicinal product should not consume grapefruit products.

FAQ's

What is Piclib?

Piclib 125 mg mainly contains palbociclib. It is a prescription medicine used in the treatment of HR+ and HER2- Breast cancer.

What dosage strengths Piclib is supplied?

Piclib is supplied in Capsules: 125 mg for oral administration.

What type of drug is Piclib?

Piclib is a type of medicine called kinase inhibitor.

How much does PICLIB- Palbociclib cost in India?

The PICLIBC- palbociclib cost in India is less and can vary. If you are looking to buy this medicine online at best price from India, then IKRIS Pharma Network (IPN) can be your one-stop solution.

Is Piclib (Palbociclib) Available In India?

Piclib is a pharmaceutical medicine that can be legally dispensed against a valid medical prescription. The medicine can be made available through a wide network of authorized distributors in India. (Delhi, Ahmedabad, Mumbai, Hyderabad, Kolkata, Chennai, Bangalore, and Pune etc.) Indian Generic Medicines(IGM) can help to get Piclib 125 mg Capsules.

Related products